|
Volumn 7, Issue 2, 2006, Pages 103-104
|
Immunomodulatory effects of non-steroidal anti-inflammatory drugs in Barrett's oesophagus [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CYCLOOXYGENASE 2;
HLA ANTIGEN;
HLA ANTIGEN CLASS 1;
HLA ANTIGEN CLASS 2;
HLA DP ANTIGEN;
HLA DQ ANTIGEN;
HLA DR ANTIGEN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ANTIGEN EXPRESSION;
ANTIGEN RECOGNITION;
ANTINEOPLASTIC ACTIVITY;
BARRETT ESOPHAGUS;
CANCER INHIBITION;
CANCER PREVENTION;
CANCER SURVIVAL;
CLINICAL TRIAL;
CORRELATION FUNCTION;
DISEASE COURSE;
ENZYME INHIBITION;
ESOPHAGEAL ADENOCARCINOMA;
ESOPHAGUS CANCER;
FOLLOW UP;
HISTOPATHOLOGY;
HODGKIN DISEASE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IMMUNOMODULATION;
LETTER;
NATURAL KILLER CELL;
PHENOTYPE;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RISK REDUCTION;
T LYMPHOCYTE;
UPREGULATION;
ADENOCARCINOMA;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BARRETT ESOPHAGUS;
DISEASE PROGRESSION;
ESOPHAGEAL NEOPLASMS;
HLA ANTIGENS;
HUMANS;
IMMUNOLOGIC FACTORS;
|
EID: 31544446056
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(06)70550-2 Document Type: Letter |
Times cited : (2)
|
References (6)
|